| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Yong Li | |
| | Paul F Robbins | |
| | John P Riley | |
| | Maria R Parkhurst | |
| | Takehito Igarashi | |
| P2860 | cites work | Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalyti | Q58380161 |
| | Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor | Q72059554 |
| | The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes | Q73163073 |
| | Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma | Q74535384 |
| | Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2) | Q77536089 |
| | Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response | Q77996343 |
| | hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization | Q24310670 |
| | Extension of life-span by introduction of telomerase into normal human cells | Q24336088 |
| | Cytotoxic T cell immunity against telomerase reverse transcriptase in humans | Q24676613 |
| | Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 |
| | The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes | Q28139460 |
| | Creation of human tumour cells with defined genetic elements | Q28141602 |
| | Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 |
| | Telomere length regulation | Q28290143 |
| | A survey of telomerase activity in human cancer | Q29614858 |
| | Can hTERT peptide (540-548) -specific CD8 T cells recognize and kill tumor cells? | Q33187012 |
| | Progress in human tumour immunology and immunotherapy | Q34253585 |
| | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma | Q36119828 |
| | Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death | Q36742412 |
| | Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A | Q37003339 |
| | Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinities | Q40649080 |
| | Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing. | Q40782201 |
| | Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase | Q41053498 |
| | Antigens recognized by T-lymphocytes on human tumours | Q41505346 |
| | Clinical implications of telomerase in cancer | Q41583670 |
| | Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase | Q42651562 |
| | Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus | Q45766815 |
| | Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. | Q51051603 |
| | Inhibition of telomerase limits the growth of human cancer cells. | Q52536487 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | 4688-4698 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase | |
| P478 | volume | 10 | |